CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Net Sales	$ 63,388,617	$ 57,300,281
Cost of Sales	64,973,157	53,598,390
Gross Profit (Loss)	(1,584,540)	3,701,891
Selling, General and Administrative	23,082,304	23,303,409
Settlement Expense, net of Reimbursement	1,030,000
Research and Product Development	5,642,317	6,321,400
Research and Development - Licenses Acquired (Related Party)	1,100,000
Operating Loss	(32,439,161)	(25,922,918)
Other Income (Expense)
Realized Gain (Loss) on Investments	(222,338)	(792,207)
Interest Income	535,328	790,226
Other Income	313	2,873
Foreign Currency Gain		742
Total Other Income (Expense)	313,303	1,634
Net Loss	$ (32,125,858)	$ (25,921,284)
Basic and Diluted Net Loss per Share	$ (0.61)	$ (0.51)
Basic and Diluted Weighted Average Shares Outstanding (in shares)	52,824,486	51,067,412